Quest Diagnostics Inc Payments for Restructuring
Quest Diagnostics Inc (DGX) reported Payments for Restructuring of $18.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2023-02-21
- Quest Diagnostics Inc payments for restructuring for the quarter ending 2014-12-31 was $11.00M, a 92.24% decline year-over-year.
- Quest Diagnostics Inc payments for restructuring for the quarter ending 2014-09-30 was $13.00M.
- Quest Diagnostics Inc payments for restructuring for the quarter ending 2014-06-30 was $43.00M.
- Quest Diagnostics Inc payments for restructuring for the quarter ending 2014-03-31 was -$17.00M.
- Quest Diagnostics Inc payments for restructuring for fiscal 2022 was $18.00M, a 38.46% increase from fiscal 2021.
- Quest Diagnostics Inc payments for restructuring for fiscal 2021 was $13.00M, a 18.75% decline from fiscal 2020.
- Quest Diagnostics Inc payments for restructuring for fiscal 2020 was $16.00M, a 36.00% decline from fiscal 2019.
- Quest Diagnostics Inc payments for restructuring for fiscal 2019 was $25.00M, a 24.24% decline from fiscal 2018.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2022-12-31 | $18.00M 10-K · filed 2023-02-21 | |||
| 2021-12-31 | $13.00M 10-K · filed 2023-02-21 | |||
| 2020-12-31 | $16.00M 10-K · filed 2021-02-22 | |||
| 2019-12-31 | $25.00M 10-K · filed 2021-02-22 | |||
| 2018-12-31 | $33.00M 10-K · filed 2020-02-20 | |||
| 2017-12-31 | $17.00M 10-K · filed 2019-02-21 | |||
| 2016-12-31 | $21.00M 10-K · filed 2018-02-23 | |||
| 2015-12-31 | $46.00M 10-K · filed 2017-02-22 | |||
| 2014-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $24.00M derived: sum of 2 quarters · filed 2016-02-26 | $67.00M derived: sum of 3 quarters · filed 2016-02-26 | $50.00M 10-K · filed 2016-02-26 |
| 2014-09-30 | $13.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $56.00M derived: sum of 2 quarters · filed 2014-10-30 | $39.00M 10-Q · filed 2014-10-30 | $180.80M derived: sum of 4 quarters · filed 2015-02-24 |
| 2014-06-30 | $43.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $26.00M 10-Q · filed 2014-07-31 | $167.80M derived: sum of 3 quarters · filed 2015-02-24 | $144.78M derived: sum of 4 quarters · filed 2015-02-24 |
| 2014-03-31 | -$17.00M 10-Q · filed 2014-05-01 | $124.80M derived: sum of 2 quarters · filed 2015-02-24 | $101.78M derived: sum of 3 quarters · filed 2015-02-24 | |
| 2013-12-31 | $141.80M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $118.78M derived: sum of 2 quarters · filed 2015-02-24 | $82.00M 10-K · filed 2015-02-24 | |
| 2013-09-30 | -$23.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-24 | -$59.80M 10-Q · filed 2013-10-24 | ||
| 2013-06-30 | -$36.77M 10-Q · filed 2013-07-25 | |||
| 2009-09-30 | -$8.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-27 | -$328.08M 10-Q · filed 2009-10-27 | ||
| 2009-06-30 | -$320.01M 10-Q · filed 2009-07-28 | |||
| 2008-09-30 | -$1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-27 | -$6.07M 10-Q · filed 2009-10-27 | ||
| 2008-06-30 | -$4.20M 10-Q · filed 2009-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |